Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Unknown journal · 2026-06-30Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-04-24Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-16Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-16An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive DisorderClinical Neuropharmacology · 2026-03-31Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-24Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in ratsResearch Square · 2026-02-22Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-17Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19An open-label pilot study of psilocybin-assisted therapy for binge eating disorderJournal of Eating Disorders · 2026-01-02Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Electrical brain changes following psilocybin administration in sprague-dawley ratsNeuroscience Applied · 2025-12-31An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in miceJournal of Psychopharmacology · 2025-12-31A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-22Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?Medical Sciences · 2025-11-19Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticityBiomedicine & Pharmacotherapy · 2025-10-29Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin CompoundsACS Omega · 2025-09-14The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-04-30Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.Journal of psychoactive drugs · 2025-04-24The phenomenology of psilocybin: transformative insights for research and clinical practiceFrontiers in Psychology · 2025-04-24187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-08Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing StudyPsyArXiv · 2025-03-06Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.Unknown journal · 2025-02-23Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.Unknown journal · 2025-02-16Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionTrials · 2024-07-02Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional OrganisationbioRxiv · 2024-06-24Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”Frontiers in Psychiatry · 2024-06-03THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.Unknown journal · 2024-05-13The Classical Psychedelic Psilocybin Mitigates Oxycodone WithdrawalJournal of Pharmacology and Experimental Therapeutics · 2024-05-12Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.Psychiatry research · 2024-04-30Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionJournal of Psychopharmacology · 2024-03-21Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Unknown journal · 2024-01-17Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.Unknown journal · 2023-11-14Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom ExtractResearch Square · 2023-07-19Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.Unknown journal · 2023-05-18Cardiac Arrest Associated With Psilocybin Use and Hereditary HemochromatosisCureus · 2023-05-06Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticityChinese Medical Journal · 2023-03-29Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users.Journal of psychoactive drugs · 2022-12-31Bedside to bench: the outlook for psychedelic research.Frontiers in pharmacology · 2022-12-31Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?Pharmaceuticals · 2022-12-30Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.Frontiers in Psychology · 2022-11-16Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.International Journal of Molecular Sciences · 2022-11-15A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.Unknown journal · 2022-09-11Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych Open · 2022-09-05P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applicationsToxicology Letters · 2022-08-31P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)Toxicology Letters · 2022-08-31Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implicationsbioRxiv · 2022-07-22Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-12Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivitymedRxiv · 2022-07-09Bacillus subtilis Produces Amino Acids to Stimulate Protein Synthesis in Ruminal Tissue Explants via the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta-Serine/Threonine Kinase-Mammalian Target of Rapamycin Complex 1 Pathway.Frontiers in Veterinary Science · 2022-06-26Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.Unknown journal · 2022-02-10Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science Advances · 2021-11-16Magic mushroom: all is not as it seems.Acta chirurgica Belgica · 2021-09-30The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.Unknown journal · 2021-09-28Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-18Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.Journal of psychiatric research · 2021-04-30[Efficacy of psychedelics in psychiatry, a systematic review of the literature].Unknown journal · 2021-04-19Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.Frontiers in Pharmacology · 2021-02-25Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.Journal of psychopharmacology (Oxford, England) · 2020-09-30The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been IdentifiedJournal of Forensic Sciences · 2020-05-05Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.Unknown journal · 2019-01-02The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.PLoS ONE · 2015-02-17Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in miceRevista Brasileira de Farmacognosia · 2010-06-30Psilocybin: reaction with a fraction of rat brain.Unknown journal · 1966-12-31Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and PsilocybinThe Journal of Psychology · 1959-12-31